Despite contacting families and arranging for a second screen to verify and quantify Hb Barts to exclude Hb H disease and confirm alpha-thalassemia trait, 45 (32.6%) newborns were lost to follow up (≥6 months). Here, GSTM1 is linked to alpha thalassemia spectrum.